Supplementary Results

Supplementary
To evaluate the effects of the truncation and G342C mutation in the prepared semisynthetic proteins, kinase assays were performed with the recombinant full-length WT, recombinant full-length G342C mutant, and semisynthetic unmodified CK2α proteins. The assay used is a continuous enzyme-coupled spectrophotometric assay that uses pyruvate kinase and lactic dehydrogenase, and monitors the disappearance of NADH (absorbance at 340nm) as an indicator of CK2α kinase activity. These enzymes contain a Gly→Cys mutation at ligation site.
Supplementary Table 2. Statistical analysis of validity of protein microarrays identifying
known CK2 substrates based on relative signal intensities. We compiled a list of validated CK2 substrates from the literature 1,2 . For those validated substrates that are also on our protein microarray chip, signal intensities are significantly higher than all the proteins printed on the chips in all the experiments, except for the negative control experiments. For these comparisons, a t test was used to compute p values and false discovery rate (FDR) was used to correct multiple testing. P value being less than 0.05 was defined as "significant".
Adjusted p value S-GlcNAc CK2α + β (1) 0.005 S-GlcNAc CK2α + β (2) 0.02 Pfa CK2α + β (1) 0.01 Pfa CK2α + β (2) 0.01 Unmodified CK2α + β (1) 0.01 Unmodified CK2α + β (2) 0.01 S-GlcNAc CK2α alone (1) 0.02 S-GlcNAc CK2α alone (2) 0.02 Pfa CK2α alone (1) 0.02 Pfa CK2α alone (2) 0.02 Unmodified CK2α alone (1) 0.01 Unmodified CK2α alone (2) 0.02 No kinase 0.08
Supplementary Table 3. Statistical analysis of validity of protein microarrays identifying
known CK2 substrates based on 3 SD cutoff. The chip assay recovered significant number of previous known substrates. Statistical significance was calculated using hypergeometric test and FDR was used to correct multiple testing. P value being less than 0.05 was defined as "significant".
Adjusted p value S-GlcNAc CK2α + β (1)
1.2x10
-05
S-GlcNAc CK2α + β (2) 0.008 Pfa CK2α + β (1) 6.4x10
-06
Pfa CK2α + β (2) 0.0005 Unmodified CK2α + β (1) 0.002 Unmodified CK2α + β (2)
1.5x10 -5 S-GlcNAc CK2α alone (1) 0.0005 S-GlcNAc CK2α alone (2) 0.007 Pfa CK2α alone (1) 0.0002 Pfa CK2α alone (2) 0.001 Unmodified CK2α alone (1) 9.0x10 Peak 1 contained multiple peptides which were not further resolved. Peaks 2 and 3 each yielded a single component and were subjected to gas-phase sequencing. Both peaks 2 and 3 yielded the identical sequence, PXXSTPVSSANh (where 'X' could not be determined from the gas phase sequencing and 'h' is homoserine lactone, the product produced from methionine upon CNBr digestion). This sequence corresponds to residues 340-351 of human CK2α. Manual Edman degradation of the purified, radiolabeled peptide showed that the saccharide is released at cycle 8, which corresponds to Ser347 in the CK2 sequence. Results of microarray array experiments are also deposited in the GEO database.
Supplementary Methods
Identification of O-GlcNAc site:
To follow CK2 during the purification from bovine brain, kinase activity was measured by incorporation of label from [γ-32 P]ATP into the CK2 peptide substrate, RRREEETEEE, in a reaction mixture containing 24 mM MOPS, pH 7.6, 80 mM NaCl, 9 mM MgCl 2 200 µM [γ- mL/min according to the previously described method 5 . Each fraction was neutralized with 50 µL of HCl and 1 M Tris HCl, pH 6.8 prior to scintillation counting. In parallel, 1 nmol of authentic Galß1-3GlcNAcitol, Galß1-4GlcNAcitol, Galß1-3GalNAcitol, Galß1-4GalNAcitol were run on the same column as standards.
Purified CK2 was desalted over a 1 mL Sephadex G-50 column into 50 mM sodium phosphate buffer (pH 7.5) to eliminate glycerol. WGA-Sepharose chromatography was performed by the previously described method 6 . Samples were applied to a 300 WGASepharose column and were washed with 5 ml of 50 mM sodium phosphate buffer (pH 7.5).
The column was washed with 6 mL of 50mM sodium phosphate buffer (pH 7.5) containing 0.5 M galactose to elute nonspecifically bound proteins. Finally, CK2 activity was specifically eluted with O.5 M N-acetylglucosamine in the same buffer. Aliquots (50 μL) of each 1 mL fraction were desalted over Sephadex G-50 equilibrated in CK2 assay buffer prior to assaying kinase activity.
Purified CK2 (100 μg) was dialyzed against deionized water to remove glycerol and lyophilized. The lyophilized sample was dissolved in 20 µL of 70% formic acid and 200 µg of cyanogen bromide was added. The sample was kept in the dark at room temperature for 24 h.
Peptide fractions were purified by binding to a Sep-Pak C18 cartridge (Waters, Millipore Division), washing in water, eluting with 60% CH 3 CN, and then lyophilized. The lyophilized sample was labeled with galactosyltransferase, as previously described. The resulting labeled peptide was purified over a Sep-Pak C-18 cartridge and analyzed by RP-HPLC on a Dynamax C-18 column with a 90 minute 0-60% CH 3 CN in 0.05% trifluoroacetic acid gradient. The flow rate was 1 mL/min, the absorbance was monitored at 214 nm. Fractions were collected every minute, and 1% of each fraction was analyzed by liquid scintillation spectrometry. Each tritium-labeled peak was pooled and separated by a second dimension RP-HPLC over a Nanobore C18 column (Rainin) with a 90 min, 0-30% CH 3 CN gradient in 0.1 M NaClO 4 , 5 mM sodium phosphate, pH 7.4. The flow rate was 0.2 mL/min, the absorbance was monitored at 214 nm and fractions were collected every min. The third dimension RP-HPLC was performed under the same conditions as the second dimension, but with the addition of 0.05% trifluoroacetic acid in the buffers instead of sodium phosphate. The tritium labeled peaks were pooled and analyzed by gas phase sequencing and manual Edman degradation.
Pure glycopeptides were sequenced by automated Edman degradation in a Model 470A Applied Biosystems gas-phase sequencer. Peptides were also subjected to the manual Edman modification protocol as previously described 7 . Prior to manual Edman degradation, peptide samples were incubated with 0.1% NH 4 OH (pH 10.7) for one day at ambient temperature and lyophilized. Incubation with dilute alkali was necessary to open the lactone ring of the C-terminal homoserine residues and allow covalent coupling to the arylamine solid support used in the Edman procedure.
Molecular cloning:
DNA encoding full-length human CK2α (aa 1-391) and truncated CK2α (aa 1-341) were each subcloned into the pTYB2 vector (New England Biolabs) using NdeI and SmaI restriction sites.
The pTYB2 vector is a C-terminal fusion vector in which the C-terminus of the target protein is fused to the Vent intein followed by CBD (chitin-binding domain). DNA encoding human CK2β was subcloned into pTYB2 using NdeI and XmaI restriction sites. Full-length G342C CK2α was prepared using the Quikchange mutagenesis protocol and the following primers: 
Synthesis of non-natural amino acids and peptide synthesis:
Phosphonodifluoromethylene alanine (Pfa) was prepared according to the procedures previously described Some of the peptides corresponding to the C-terminal tail of CK2α prepared for expressed protein ligation showed evidence on the HPLC chromatograms of multiple conformations attributed to the several prolines found in these peptides. In these cases, multiple peaks corresponding to pure material with the same mass were collected during HPLC purification and combined. The ultimate purity of the peptides used was based on the MALDI-MS spectra. MESNA, in cleavage buffer, pH 7.5), and the column is sealed and purged with nitrogen gas.
The ligation reaction is allowed to proceed for approximately 60 h at rt. Upon completion of ligation reaction, the semisynthetic CK2α protein is washed and collected from the column with cleavage buffer plus 1 mM phenylmethysulfonylfluoride (PMSF), dialyzed extensively against 50 mM Hepes, 500 mM NaCl, 1 mM EDTA, 10 mM DTT, 10% glycerol to remove the MESNA and unligated peptide, concentrated to >1 mg/mL, and stored at -80°C. Protein purity and concentrations were evaluated by Coomassie stained 12% SDS-PAGE and Bradford assay (BioRad) using bovine serum albumin (BSA) as a standard.
The other recombinant CK2 proteins (full-length CK2α, G342C CK2α, and CK2β) were expressed and purified in a manner similar to that described above with the noted exceptions.
Following the wash steps, instead of adding ligation reaction mixture, the full-length recombinant proteins were eluted from the chitin beads with either 50 mM DTT or 4 mM Lcysteine in 50 mM Hepes pH 7.5, 250 mM NaCl, 1 mM EDTA at rt for 16 h.
Steady-state kinetic kinase assays using peptide substrates:
To determine the kinetic parameters, radiometric kinase assays were carried out in 50 mM
Hepes (pH 7.5), 75 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, 5% glycerol, 250 μg/mL BSA using the biotinylated peptide substrates described above in a 25 μL reaction volume with various ATP and peptide concentrations. Reactions were initiated by the addition of kinase (10 nM final concentration), carried out at 30°C for 2-16 min, and stopped by the addition of 10 μL of 100 mM EDTA. To each sample, 10 μL of 10 mg/mL avidin (Thermo Scientific) was added, and all samples were transferred to centrifugal filtration units with 30,000 nominal molecular weight limit (NMWL) membranes (Millipore) and washed three times with 100 μL wash solution In addition to determining cell viability using diacetyl fluorescein and propidium iodide 11 , the viability of the microinjected cells was also evaluated by examining the nuclei and demonstrating that they are still intact following injections. REF52 cells were microinjected with recombinant HA-CK2α protein in the same way as described above and were incubated at 37 °C in 5% CO 2 for 2 h before being fixed and immunostained (see description above). In addition to anti-HA (1:4000 Covance) for detecting CK2α injected protein, cells were also stained with anti-lamin A (1:200 Santa Cruz) and DAPI (33 ng/mL). Images of samples were obtained with both an Olympus BX61 microscope (as described before) and also with a Zeiss Each treatment condition was performed with at least 2 biological duplicate samples.
Data analysis of protein microarray data:
The scanned images of the exposed film for the microarray chips were imported into GenePix Pro Software. Signal intensity of each spot on the microarray chips was quantified by dividing the median foreground intensity by its median background intensity. To correct for the variance that are non-uniformly distributed on the chips, signal intensities of a set of spots within a block on a chip were normalized by setting the median intensity of that block equal to one, based on the assumption that proteins are randomly printed and only a limited number of proteins on a microarray are substrates of a kinase. As the distribution of signal intensities of all the proteins follows a normal distribution (see Supplementary Results Fig. 17 and 24) , we used the standard deviation (SD) value to determine the cutoff value as previously described method 12 .
A stringent cutoff of three SDs was used to increase the chances of a low false positive rate.
Moreover, proteins identified as "positive hits" in both duplicate experiments were qualified as a "substrate" for a given experiment. To be included in Table 2 , the "positive hit" could not have shown to be positive in either of the duplicate experiments for the other CK2 enzyme forms. See Supplementary Dataset 1 for signal intensities.
Purification of substrate proteins from yeast:
The following proteins were selected for the validation studies and were expressed and purified in yeast: AHCYL2, NAP1L3, EEF2K, WASPL, PCDL2, and UBE2O. DNA encoding these proteins was subcloned into the pEGH-A vector 13 using Gateway LR Clonase reactions (Invitrogen) and the plasmids were transformed into WT Y258A yeast strain using standard
LiOAc protocol. Transformed cells were grown in URA-/raffinose liquid media (50-mL culture)
at 30°C until cell density reached OD 600 =0.6-0.8, then induced with 2% galactose for overexpression for 8 h. Cells were collected by centrifugation at 4500 RPM, washed with ddH 2 0, and flash frozen in liquid N 2 . Frozen cell pellets were lysed in lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 1 mM EGTA, 10% glycerol, 0.1% Triton X-100, 0.1% βME, 1 mM PMSF, plus Roche Protease inhibitor tablet) with 2 mL zirconia beads (Biospec) and 16 x 100 s intervals of shaking on paint shaker at 4°C. Lysed samples were centrifuged at 4000 RPM for 22 min and the clarified supernatant was loaded onto 225 μL of glutathione agarose beads.
Protein was bound to glutathione beads at 4°C on nutator for 1 h and beads were washed 3x with 50 mM Tris pH 7.5, 500 mM NaCl, 1 mM EGTA, 10% glycerol, 0.1% Triton X-100, 0.1% βMe, 1 mM PMSF and washed 3x with 50 mM Hepes pH 7.5, 100 mM NaCl, 1 mM EGTA, 10% glycerol, 0.1% βMe, 1 mM PMSF. Proteins were eluted with 50 mM Hepes pH 8.0, 100 mM NaCl, 10% glycerol, 40 mM glutathione (reduced form), 0.03% Triton X-100, 1 mM PMSF.
Protein purity and concentrations were evaluated by Coomassie stained 10% SDS-PAGE using BSA as a standard.
Purification of NIPBL from E. coli:
NIPBL was selected for validation studies and was expressed and purified in E. coli. NIPBL DNA was subcloned into pDEST17 (N-terminal 6xHis tag) using a Gateway LR Clonase reaction and the plasmid was transformed into E. coli BL21 DE3 cells. Transformed cells were grown at 37°C in LB media for 2 h until cell density reached OD 600 =0.6, then induced at 16°C
with 350 μM IPTG for overexpression for 20 h. Cell pellet was harvested by centrifugation and lysed via double-pass on French press in 25 mM Tris pH 8, 500 mM NaCl, 10 mM imidazole, 10 mM βME, 0.1% Tween, and cell lysates were clarified by centrifugation at 15,000 RPM.
The supernatant was loaded onto Ni-NTA column, washed with 25 mM Tris pH 8, 500 mM NaCl, 10 mM imidazole, 10 mM βME, and protein was eluted with wash buffer containing 50, 100, 250, and 500 mM imidazole. Purified NIPBL was dialyzed into 50 mM Hepes pH 7.5, 100 mM NaCl, 10% glycerol, 0.1% βME. Protein purity and concentration was evaluated by 12% SDS-PAGE stained with Coomassie using BSA as a standard.
Solution phase kinase assays with selected protein substrates from protein microarrays:
To determine the kinase activity for the differently modified CK2α enzymes with candidate protein substrates from protein chips, solution phase radiometric kinase assays were carried out in 50 mM Hepes (pH 7.5), 10 mM MgCl 2 , 80 mM NaCl, 1 mM DTT, 0.08 μg/μL BSA, 0.015% Triton, 6.6% glycerol, 100 μM ATP, and 20 mM glutathione with various protein substrates in a 24 μL reaction volume with 10 nM CK2α ± 11 nM CK2β. The glutathione was present as a result of the preparation and purification of the substrate proteins as GST fusions.
Reactions were initiated by the addition of kinase carried out at 30°C for 6-18 min, and stopped by the addition of 5 μL of 200 mM EDTA and 6 μL 6x-SDS loading buffer. The CK2 α and β subunits were allowed to incubate on ice for at least 30 min prior to initiating the assays. Each sample was loaded into two 10% Tris-Glycine gels (170V). One set of gels was washed in ddH 2 0, dried on filter paper, and exposed to phosphoimager screen for 2-8 h. The other set of gels were stained with Coomassie, and the bands corresponding to protein substrates were cut and counted using liquid scintillation counter to determine the amount of 32 P incorporated into the band. Kinase assays for NIPBL were carried out by the same procedure with the following conditions: 50 mM Hepes (pH 7.5), 10 mM MgCl 2 , 80 mM NaCl, 1 mM DTT, 250 μg/mL ovalbumin, 0.1% NP-40, 5% glycerol, 100 μM ATP, and with 50 ng/μL NIPBL protein substrate in a 24 μL reaction volume with 10 nM CK2α ± 11 nM Pin1. CK2α and Pin1 were allowed to incubate on ice for at least 30 min prior to initiating the assays. Reactions were carried out at 30°C for 5 min and samples were loaded onto 12% Tri-Glycine gel.
CK2 kinase assays for calmodulin substrate:
To determine the extent that the semisynthetic CK2α enzymes are able to phosphorylate calmodulin protein substrate, radiometric kinase assays were carried out in 50 mM Tris (pH 7.5), 75 mM NaCl, 12 mM MgCl 2 , 1 mM DTT, 5% glycerol, 100 μg/mL BSA using 0.25 mg/mL calmodulin (Sigma) and 200 μM ATP. Reactions were initiated by the addition of kinase (100 nM final concentration CK2α), carried out at 30°C for 10 min in a 28 μL reaction volume, and stopped by the addition of 10 μL of 100 mM EDTA and 10 μL 5x-SDS loading buffer. Samples were loaded into 15% Tris-Glycine gel and gels were run at 130V, stained with Coomassie, and the bands corresponding to calmodulin were cut from the gel. The amount of 32 P incorporated into the band was determined using liquid scintillation counting. Various amounts of CK2β (0, 50, 100, 200 nM final concentration) were added to CK2α sample prior to the initiation of the reaction.
Spectrophotometric kinase assays for CK2 specific activities:
To evaluate the effects of the truncation and G342C mutation in the prepared semisynthetic proteins, continuous enzyme-coupled spectrophotometric assays were performed using pyruvate kinase and lactic dehydrogenase, and monitoring the disappearance of NADH 
